166 related articles for article (PubMed ID: 12972735)
1. HCG tests in the management of gestational trophoblastic diseases.
Cole LA; Sutton JM
Clin Obstet Gynecol; 2003 Sep; 46(3):523-40. PubMed ID: 12972735
[No Abstract] [Full Text] [Related]
2. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
3. Follow-Up After Molar Pregnancy Evacuation: Feasibility of Using Semi-Quantitative Urine Pregnancy Tests.
Hoppenot C; Zimmerman L; Arlandson M; Lurain JR; Patel A
J Reprod Med; 2016; 61(5-6):192-6. PubMed ID: 27424357
[TBL] [Abstract][Full Text] [Related]
4. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
Cole LA; Kohorn EI; Kim GS
J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
6. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
7. Gestational Trophoblastic Disease Diagnosis Delayed by the Hook Effect.
Cormano J; Mackay G; Holschneider C
Obstet Gynecol; 2015 Oct; 126(4):811-814. PubMed ID: 26132453
[TBL] [Abstract][Full Text] [Related]
8. [The kinetics of chorionic gonadotropin and its subunits in normal pregnancy and gestational trophoblastic neoplasms].
Kunhardt J; Calderón J; Rodríguez S; Fletcher P; Ayala A; Reyes V
Ginecol Obstet Mex; 1987 Jul; 55():188-91. PubMed ID: 2484840
[No Abstract] [Full Text] [Related]
9. Second curettage in persistent trophoblastic disease (PTD): the need for univocal definition of PTD.
van Trommel NE; Thomas CM; Massuger LF; Sweep FC
Gynecol Oncol; 2005 Oct; 99(1):250-1; author reply 251. PubMed ID: 16224821
[No Abstract] [Full Text] [Related]
10. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.
Cole LA; Kohorn EI
J Reprod Med; 2006 Oct; 51(10):793-811. PubMed ID: 17086808
[TBL] [Abstract][Full Text] [Related]
11. Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin.
Sturgeon CM; Berger P; Bidart JM; Birken S; Burns C; Norman RJ; Stenman UH;
Clin Chem; 2009 Aug; 55(8):1484-91. PubMed ID: 19541864
[TBL] [Abstract][Full Text] [Related]
12. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
Cole LA; Sutton JM
J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
[TBL] [Abstract][Full Text] [Related]
13. False-positive beta-human chorionic gonadotropin values in the follow-up of gestational trophoblastic disease.
Díaz Muñoz de la Espada VM; Arranz Arija JA; Khosravi Shahi P; Encinas García S; Alvarez Alvarez R; González Beca R
Clin Transl Oncol; 2007 May; 9(5):332-4. PubMed ID: 17525045
[TBL] [Abstract][Full Text] [Related]
14. Discordant results in human chorionic gonadotropin assays.
Cole LA; Kardana A
Clin Chem; 1992 Feb; 38(2):263-70. PubMed ID: 1371722
[TBL] [Abstract][Full Text] [Related]
15. Placental site trophoblastic tumour: the rarest subtype of gestational trophoblastic disease.
Chaves MM; Maia T; Cunha TM; Veiga VF
BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33040035
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of patients with persistent low-level elevation of human chorionic gonadotrophin.
Qian XQ; Chen LL; Li BH; Cheng XD; Wan XY
J Obstet Gynaecol Res; 2016 Jun; 42(6):694-700. PubMed ID: 26916449
[TBL] [Abstract][Full Text] [Related]
17. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
[TBL] [Abstract][Full Text] [Related]
18. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
[TBL] [Abstract][Full Text] [Related]
19. Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases.
Cole LA
Int J Gynecol Cancer; 2014 Nov; 24(9):1709-14. PubMed ID: 25275660
[TBL] [Abstract][Full Text] [Related]
20. Elevated hCG and a high proportion of hCGbeta in serum preceding the diagnosis of trophoblastic disease by seven months.
Vartiainen J; Alfthan H; Lehtovirta P; Stenman UH
BJOG; 2002 May; 109(5):589-90. PubMed ID: 12066956
[No Abstract] [Full Text] [Related]
[Next] [New Search]
